Hilde D.
- Country
- Belgium
- Department
- N/A
Research Overview
- A Comparative Study of Somapacitan and Somatropin in Pediatric Patients with Short Stature Due to SGA, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
- Evaluation of Somatropin and Letrozole in Enhancing Adult Height in Boys with Short Predicted Stature: A 4-Year Randomized Controlled Trial
Data & Insights
Has run more than one trial at 1 of 43 partner sites.
Specializations
Pediatric Growth Disorders
The investigator specializes in treating various conditions affecting children's growth, with particular focus on short stature disorders and their management through hormone therapy.
- Small for Gestational Age (SGA)
- Turner Syndrome
- Noonan Syndrome
- Idiopathic Short Stature
Expertise includes evaluating growth patterns and implementing targeted therapeutic interventions for optimal height outcomes.
Growth Hormone Therapy
Focuses on innovative approaches to growth hormone treatment, including both daily and weekly administration protocols for pediatric patients.
- Long-acting Growth Hormone Formulations
- Customized Treatment Protocols
- Height Velocity Assessment
Specialized in determining optimal timing and duration of hormone therapy for maximum growth potential.
Pubertal Development
Expert in managing growth optimization during puberty, including combined therapeutic approaches for height improvement.
- Puberty-related Growth Patterns
- Height Prediction Analysis
- Combination Therapy Approaches
Utilizes advanced treatment strategies to enhance final adult height outcomes in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.